These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 13371902)

  • 21. Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
    Hershfield ES; Eidus L; Helbecque DM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):387-93. PubMed ID: 115802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological studies on the resistance of Mycobacterium tuberculosis against streptomycin and other tuberculostatic drugs].
    POTHMANN FJ
    Ergeb Hyg Bakteriol Immunitatsforsch Exp Ther; 1955; 29():248-393. PubMed ID: 13241442
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study on infection with drug resistant tubercle bacilli from patients among the already tuberculin-positive persons without tuberculous lesions in a workshop].
    KOIKE S; MURASE S; OOMI A
    Kekkaku; 1962 Apr; 37():188-94. PubMed ID: 14457874
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid.
    JOSIUKAS A; ROY TE; BOYD G
    AMA Am J Dis Child; 1952 Dec; 84(6):747-8. PubMed ID: 12996007
    [No Abstract]   [Full Text] [Related]  

  • 25. [Result of sensitivity evaluation of human, bovine and avian tuberculosis bacteria].
    NASSAL J; PETERSEN KF
    Tuberkulosearzt; 1961 Sep; 15():589-97. PubMed ID: 14478466
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin.
    FRIEDMAN B; SALE L; GOLDMAN A
    Am J Med Sci; 1952 Jul; 224(1):53-6. PubMed ID: 14933413
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 28. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 29. [Resistance of tuberculosis bacilli to antibiotics].
    DESBORDES J; FOURNIER E; ROSENBERG E; ALIX D
    Ann Biol Clin (Paris); 1956; 14(5-6):423-8. PubMed ID: 13340278
    [No Abstract]   [Full Text] [Related]  

  • 30. Cultural properties of M. tuberculosis in resected pulmonary lesions of patients treated with streptomycin and para-aminosalicylic acid.
    GRANVILLE GE; JENKINS DE; COOLEY DA; DEBAKEY ME; WHITCOMB FC; HALPERT B
    Am Rev Tuberc; 1953 Nov; 68(5):727-33. PubMed ID: 13104885
    [No Abstract]   [Full Text] [Related]  

  • 31. [Streptomycin and PAS resistance of tubercle bacteria isolated from patients with tuberculous meningitis].
    VAN ZEBEN W; VAN GENDEREN H; MANTEN A
    Maandschr Kindergeneeskd; 1952 Apr; 20(3):69-83. PubMed ID: 14940043
    [No Abstract]   [Full Text] [Related]  

  • 32. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug susceptibility of mycobacterium tuberculosis isolates in Asmara.
    Lemma E; Gebre-Yohannes A
    Ethiop Med J; 1984 Apr; 22(2):105-6. PubMed ID: 6202515
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteriology of tuberculosis].
    CETRANGOLO A
    Rev Med Cordoba; 1956 Feb; 44():42-55. PubMed ID: 13336737
    [No Abstract]   [Full Text] [Related]  

  • 36. [A new rapid determination method of resistance applying the color reaction of tubercle bacilli].
    KAWAI K
    Kekkaku; 1955 Nov; 30(11):621-7. PubMed ID: 13286843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Koch bacillus resistance to antibiotics in the inoculated and antibiotic-treated guinea pig].
    LE MELLETIER J; BROWAEYS J; CAULET T
    Ann Biol Clin (Paris); 1955; 13(5-6):305-8. PubMed ID: 13249138
    [No Abstract]   [Full Text] [Related]  

  • 38. [A study on PAS-resistance; its relation to clinical symptoms and SM-resistance, the change of resistance in the course of treatment].
    ITO Y; KONDO H
    Kekkaku; 1955 Nov; 30(11):643-7. PubMed ID: 13286847
    [No Abstract]   [Full Text] [Related]  

  • 39. Mode of action of anti-tubercular drugs.
    Santhanam K; Venkitasubramanian TA
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):192-207. PubMed ID: 96023
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 2. An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM), isonicotinic acid hydrazide (INH) and/or para-aminosalicylic acid (PAS)].
    FUKUI A
    Kekkaku; 1959 Dec; 34():851-6. PubMed ID: 13825600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.